Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block
- PMID: 8724310
Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block
Abstract
Objective: To compare the subclass distribution of anti-48 kDa La(SSB) and anti-52 and 60 kDa Ro(SSA) antibodies in the maternal and neonatal circulation, in pregnancies affected and unaffected by the development of congenital heart block (CHB).
Methods: Sera were obtained from 32 mothers (during 34 pregnancies 23 complicated by CHB and 11 healthy) demonstrated to have anti-Ro(SSA) and/or La(SSB). Maternal and neonatal autoantibodies were evaluated for subclass distribution by ELISA:
Results: All 4 subclasses of anti-Ro(SSA) and La(SSB) antibodies cross the placenta and are detectable in sera obtained from the umbilical cord, IgG1 and IgG3 were the major subclasses represented in the 48 kDa La(SSB) and 52 kDa Ro(SSA) responses. All subclasses, including IgG2 and IgG4, were observed in about one-third of the anti-52 kDa Ro(SSA) and 48 kDa La(SSB) responses. In contrast, anti-60 kDa antibodies were, with rare exception, confined to IgG1. Except for anti-48 kDa La(SSB) IgG3 antibodies, no significant differences were observed between affected and unaffected pregnancies in the ratio of maternal to neonatal levels of any of the antibody subclasses. Overall, there were no significant differences in the subclass profiles between mothers whose children had heart block and those who did not.
Conclusion: The IgG subclasses of anti-48 kDa La(SSB) and anti-52 and 60 kDa Ro(SSA) do not account for the susceptibility of one fetus versus another for the development of CHB. Anti-60 kDa Ro(SSA) antibodies are more restricted in subclass distribution than anti-52 kDA Ro(SSA) or 48 kDa La(SSB) responses.
Similar articles
-
Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.J Rheumatol. 1994 Oct;21(10):1943-50. J Rheumatol. 1994. PMID: 7837164
-
[Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].Ann Med Interne (Paris). 2002 Dec;153(8):520-9. Ann Med Interne (Paris). 2002. PMID: 12610426 Review. French.
-
Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.J Rheumatol. 2004 Jan;31(1):183-9. J Rheumatol. 2004. PMID: 14705240
-
Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block.Ann Med Interne (Paris). 1997;148(3):205-8. Ann Med Interne (Paris). 1997. PMID: 9255327 Review.
-
Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):167-71. doi: 10.1016/j.ejogrb.2005.01.013. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 16219517
Cited by
-
Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.Arthritis Rheum. 2010 Apr;62(4):1138-46. doi: 10.1002/art.27308. Arthritis Rheum. 2010. PMID: 20391423 Free PMC article. Clinical Trial.
-
Neonatal lupus.Clin Rev Allergy Immunol. 2002 Dec;23(3):279-99. doi: 10.1385/CRIAI:23:3:279. Clin Rev Allergy Immunol. 2002. PMID: 12402413 Review.
-
Clinical relevance of autoantibodies in systemic rheumatic diseases.Mol Biol Rep. 1996;23(3-4):133-45. doi: 10.1007/BF00351161. Mol Biol Rep. 1996. PMID: 9112221 Review.
-
An Overview of Neonatal Lupus with Anti-Ro Characteristics.Int J Mol Sci. 2021 Aug 27;22(17):9281. doi: 10.3390/ijms22179281. Int J Mol Sci. 2021. PMID: 34502221 Free PMC article. Review.
-
Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block.J Immunol. 2010 Feb 15;184(4):2148-55. doi: 10.4049/jimmunol.0902248. Epub 2010 Jan 20. J Immunol. 2010. PMID: 20089705 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials